ArticleJAAD international2025

Pemphigus risk following programmed death receptor-1, programmed death ligand-1, or cytotoxic T-lymphocyte-associated protein 4 inhibitors: A 1:1 propensity-matched, global, retrospective cohort study.

Justin Baroukhian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.